APP Pharmaceuticals, LLC v. Navinta LLC

181 L. Ed. 2d 39, 132 S. Ct. 115, 565 U.S. 825, 2011 U.S. LEXIS 5450, 80 U.S.L.W. 3182
Supreme Court of the United States·Decided October 3, 2011·No. No. 10-1502·Published

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

[40]*40Same case below, 625 F.3d 1359.

Free access — add to your briefcase to read the full text and ask questions with AI

APP Pharmaceuticals, LLC v. Navinta LLC, 181 L. Ed. 2d 39, 132 S. Ct. 115, 565 U.S. 825, 2011 U.S. LEXIS 5450, 80 U.S.L.W. 3182 (U.S. 2011).

181 L. Ed. 2d 39 (APP Pharmaceuticals, LLC v. Navinta LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Abraxis Bioscience, Inc. v. NAVINTA LLC
625 F.3d 1359 (Federal Circuit, 2010)